Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Ch
- This topic has 0 replies, 1 voice, and was last updated 7 years, 1 month ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma.
https://www.ncbi.nlm.nih.gov/pubmed/28545228
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.